Optimal Management of Patients with Cancer-associated Venous Thromboembolism: The Important Role of Anticoagulation Therapy
Saturday, June 4, 2022
7:45 PM – 8:45 PM ET
6:45 PM – 7:45 PM CT
5:45 PM – 6:45 PM MT
4:45 PM – 5:45 PM PT
Learning Objectives
After participating in this educational initiative, clinicians should be better able to:
- Facilitate optimal management of patients with cancer-associated VTE based on risk stratification assessments
- Assess data from clinical trials supporting anticoagulants for the treatment of patients with cancer-associated VTE
- Select appropriate therapies for patients with cancer-associated VTE using recently updated evidence-based guidance from professional organizations
- Optimize outcomes for patients with cancer-associated VTE through adoption of multidisciplinary patient-centered SDM management approaches
Target Audience
This activity is intended for medical oncologists, community oncologists, primary care providers, allied healthcare professionals ie, nurse practitioners, physician assistants, pharmacists, VTE specialists, and/or other healthcare professionals involved in the care of patients with cancer.
Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
Credit Designation Statement
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Nursing Credit Information
Purpose: Education regarding the management of VTE in cancer leads to safe practices, quality care, and continued professional and personal development for oncology nurses. CNE Credits: 1.0 ANCC Contact Hour.
Accreditation Statement
Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hours of continuing nursing education of RNs and APNs.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosure Of Unlabeled Use
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact: Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/
Release date: June 04, 2022
Expiration date: June 04, 2023
Estimated time to completion: 1 hour
